Self-inhibition by dopaminergic neurons.
D000200:Action Potentials / Q000187:drug effects; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D005246:Feedback; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D008959:Models, Neurological; D009434:Neural Pathways; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D018377:Neurotransmitter Agents / Q000502:physiology; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*
D018492:Dopamine Antagonists; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D000661:Amphetamine; D006220:Haloperidol; D004298:Dopamine